Severe Ulceronecrotic Evolution during Mogamulizumab Treatment in a Patient with Primary Cutaneous Peripheral T-cell Lymphoma.

Quentin Samaran; Marilou Duboëlle; Anaïs Marque; Virginie Brès; O Dereure

doi:10.2340/actadv.v106.adv-2025-0279

← 뒤로

Severe Ulceronecrotic Evolution during Mogamulizumab Treatment in a Patient with Primary Cutaneous Peripheral T-cell Lymphoma.

1/5 보강

Acta dermato-venereologica 📖 저널 OA 68.2% 2021~2026 2026 Vol.106() OA Cutaneous lymphoproliferative disord

OpenAlex 토픽 · Cutaneous lymphoproliferative disorders research T-cell and Retrovirus Studies Lymphoma Diagnosis and Treatment

Samaran Q, Duboëlle M, Marque A, Bres V, Dereure O

📖 무료 전문 🟢 PMC 전문 PMC13094340 🔓 OA PDF oa

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Quentin Samaran, Marilou Duboëlle, et al. (2026). Severe Ulceronecrotic Evolution during Mogamulizumab Treatment in a Patient with Primary Cutaneous Peripheral T-cell Lymphoma.. Acta dermato-venereologica, 106. https://doi.org/10.2340/actadv.v106.adv-2025-0279

MLA Quentin Samaran, et al.. "Severe Ulceronecrotic Evolution during Mogamulizumab Treatment in a Patient with Primary Cutaneous Peripheral T-cell Lymphoma.." Acta dermato-venereologica, vol. 106, 2026.

PMID 42007812 ↗

DOI 10.2340/actadv.v106.adv-2025-0279

같은 제1저자의 인용 많은 논문 (1)

Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system.
European journal of cancer (Oxford, England : 1990) 2026